Neu differentiation factor (NDF), a dominant oncogene, causes apoptosis in vitro and in vivo - PubMed (original) (raw)
Neu differentiation factor (NDF), a dominant oncogene, causes apoptosis in vitro and in vivo
S Grimm et al. J Exp Med. 1998.
Abstract
Neu differentiation factor (NDF, also called neuregulin) is a potent inducer of epithelial cell proliferation and has been shown to induce mammary carcinomas in transgenic mice. Notwithstanding this proliferative effect, we have shown that a novel isoform of NDF can induce apoptosis when overexpressed. Here we report that this property also extends to other NDF isoforms and that the cytoplasmic portion of NDF is largely responsible for the apoptotic effect, whereas the proliferative activity is likely to depend upon the secreted version of NDF. In accordance with these contradictory properties, we find that tumors induced by NDF display extensive apoptosis in vivo. NDF is therefore an oncogene whose deregulation can induce transformation as well as apoptosis.
Figures
Figure 1
Apoptosis induction of NDF deletion mutants with and without a signal sequence. The domains of wild-type β2b NDF are indicated on top of the diagrammatic representation. IG, immunoglobulin homology domain; Glyco, glycosylated domain; EGF, epidermal growth factor domain; β, sequences of β exon; 2, sequences of exon 2; TM, transmembrane domain; Cyto, cytoplasmic domain; b, sequences of b exon; Sig, signal sequence of erbB-3. The names of the deletion constructs denote the deleted amino acids of wild-type β2b NDF. As a control in the case of the constructs that did not induce apoptosis (Δ 2-262, Sig Δ 2-262, and Δ 2-198), myc-tagged versions were transfected into BHK cells and the protein products were analyzed on SDS gels and detected with anti-myc-tag antibody. In each case, protein of appropriate mobility was detected (data not shown). 1.5 μg of each expression construct were transfected into BHK cells with 1 μg of a β-gal expression vector. 24 h after transfection the cells were stained for β-gal activity and the percentage of apoptotic and blue cells of all blue cells was determined using morphological inspection. Shown are the means and SD of at least 1,000 counted cells of four independent transfections.
Figure 2
Apoptosis induction by different NDF isoforms. Expression plasmids (4 μg) of the indicated NDF isoforms or of TGF-α were transfected together with a β-gal vector (1 μg) into BHK cells. Apoptosis induction was measured as in Fig. 1. The structure of each NDF isoform is schematically depicted in the diagram. Each subdomain is named as in Fig. 1. α and a denote the α or the a exon in the extra- or intracellular domain, respectively.
Figure 3
Apoptosis induction in NDF-caused tumors. Hematoxylin and eosin–stained tissues from an adenocarcinoma in the mammary gland of NDF-transgenic mice, WT mammary gland, and a myc-induced tumor were probed with the TUNEL technique that detects DNA ends that are generated during apoptosis.
Figure 4
Model for the apoptotic and tumorigenic activity of NDF. A cell that overexpresses the NDF-precursor releases high amounts of the secreted NDF form. Its interaction with erbB receptors can lead to the subsequent proliferation of neighboring cells and might constitute the first step towards transformation. NDF's apoptosis-inducing activity is concomitantly activated when NDF is overexpressed and thereby kills this potentially dangerous cell.
Similar articles
- Effect of neu differentiation factor isoforms on neonatal oligodendrocyte function.
Raabe TD, Suy S, Welcher A, DeVries GH. Raabe TD, et al. J Neurosci Res. 1997 Dec 1;50(5):755-68. doi: 10.1002/(SICI)1097-4547(19971201)50:5<755::AID-JNR12>3.0.CO;2-0. J Neurosci Res. 1997. PMID: 9418963 - ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes.
Marikovsky M, Lavi S, Pinkas-Kramarski R, Karunagaran D, Liu N, Wen D, Yarden Y. Marikovsky M, et al. Oncogene. 1995 Apr 6;10(7):1403-11. Oncogene. 1995. PMID: 7731691 - Proliferation of human Schwann cells induced by neu differentiation factor isoforms.
Baek SY, Kim SU. Baek SY, et al. Dev Neurosci. 1998;20(6):512-7. doi: 10.1159/000017351. Dev Neurosci. 1998. PMID: 9858839 - Neu and its ligands: from an oncogene to neural factors.
Peles E, Yarden Y. Peles E, et al. Bioessays. 1993 Dec;15(12):815-24. doi: 10.1002/bies.950151207. Bioessays. 1993. PMID: 7908191 Review.
Cited by
- Neuregulin-1, a potential therapeutic target for cardiac repair.
Wang Y, Wei J, Zhang P, Zhang X, Wang Y, Chen W, Zhao Y, Cui X. Wang Y, et al. Front Pharmacol. 2022 Aug 31;13:945206. doi: 10.3389/fphar.2022.945206. eCollection 2022. Front Pharmacol. 2022. PMID: 36120374 Free PMC article. Review. - CKMT1 regulates the mitochondrial permeability transition pore in a process that provides evidence for alternative forms of the complex.
Datler C, Pazarentzos E, Mahul-Mellier AL, Chaisaklert W, Hwang MS, Osborne F, Grimm S. Datler C, et al. J Cell Sci. 2014 Apr 15;127(Pt 8):1816-28. doi: 10.1242/jcs.140467. Epub 2014 Feb 12. J Cell Sci. 2014. PMID: 24522192 Free PMC article. - The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene.
Chua YL, Ito Y, Pole JC, Newman S, Chin SF, Stein RC, Ellis IO, Caldas C, O'Hare MJ, Murrell A, Edwards PA. Chua YL, et al. Oncogene. 2009 Nov 19;28(46):4041-52. doi: 10.1038/onc.2009.259. Epub 2009 Oct 5. Oncogene. 2009. PMID: 19802002 Free PMC article. - Roles for neuregulins in human cancer.
Stove C, Bracke M. Stove C, et al. Clin Exp Metastasis. 2004;21(8):665-84. doi: 10.1007/s10585-004-6917-6. Clin Exp Metastasis. 2004. PMID: 16035612 Review. - Back signaling by the Nrg-1 intracellular domain.
Bao J, Wolpowitz D, Role LW, Talmage DA. Bao J, et al. J Cell Biol. 2003 Jun 23;161(6):1133-41. doi: 10.1083/jcb.200212085. J Cell Biol. 2003. PMID: 12821646 Free PMC article.
References
- Wen D, Peles E, Cupples R, Suggs SV, Bacus SS, Luo Y, Trail G, Hu S, Silbiger SM, Ben-Levy R, et al. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell. 1992;69:559–572. - PubMed
- Holmes WE, Sliwkoski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Paab H, Lewis GD, et al. Identification of heregulin, a specific activator of p185 erbB2. Science. 1992;256:1205–1209. - PubMed
- Krane IM, Leder P. NDF/Heregulin induced persistence of terminal end buds and adenocarcinomas in the mammary gland of transgenic mice. Oncogene. 1996;12:1781–1789. - PubMed
- Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell. 1990;61:1137–1146. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous